Literature DB >> 20651275

Small GTPase RhoA and its effector rho kinase mediate oxygen glucose deprivation-evoked in vitro cerebral barrier dysfunction.

Claire Allen1, Kirtiman Srivastava, Ulvi Bayraktutan.   

Abstract

BACKGROUND AND
PURPOSE: Enhanced vascular permeability attributable to disruption of blood-brain barrier results in the development of cerebral edema after stroke. Using an in vitro model of the brain barrier composed of human brain microvascular endothelial cells and human astrocytes, this study explored whether small GTPase RhoA and its effector protein Rho kinase were involved in permeability changes mediated by oxygen-glucose deprivation (OGD), key pathological phenomena during ischemic stroke.
METHODS: OGD increased RhoA and Rho kinase protein expressions in human brain microvascular endothelial cells and human astrocytes while increasing or unaffecting that of endothelial nitric oxide synthase in respective cells. Reperfusion attenuated the expression and activity of RhoA and Rho kinase in both cell types compared to their counterparts exposed to equal periods of OGD alone while selectively increasing human brain microvascular endothelial cells endothelial nitric oxide synthase protein levels. OGD compromised the barrier integrity as confirmed by decreases in transendothelial electric resistance and concomitant increases in flux of permeability markers sodium fluorescein and Evan's blue albumin across cocultures. Transfection of cells with constitutively active RhoA also increased flux and reduced transendothelial electric resistance, whereas inactivation of RhoA by anti-RhoA Ig electroporation exerted opposite effects. In vitro cerebral barrier dysfunction was accompanied by myosin light chain overphosphorylation and stress fiber formation. Reperfusion and treatments with a Rho kinase inhibitor Y-27632 significantly attenuated barrier breakdown without profoundly altering actin structure.
CONCLUSIONS: Increased RhoA/Rho kinase/myosin light chain pathway activity coupled with changes in actin cytoskeleton account for OGD-induced endothelial barrier breakdown.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20651275     DOI: 10.1161/STROKEAHA.109.574939

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  26 in total

Review 1.  Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.

Authors:  Xiaoming Hu; T Michael De Silva; Jun Chen; Frank M Faraci
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

Review 2.  Role of the Golgi Apparatus in the Blood-Brain Barrier: Golgi Protection May Be a Targeted Therapy for Neurological Diseases.

Authors:  Shuwen Deng; Hui Liu; Ke Qiu; Hong You; Qiang Lei; Wei Lu
Journal:  Mol Neurobiol       Date:  2017-07-20       Impact factor: 5.590

3.  Inhibition of Rho kinase by hydroxyfasudil attenuates brain edema after subarachnoid hemorrhage in rats.

Authors:  Mutsumi Fujii; Kamil Duris; Orhan Altay; Yoshiteru Soejima; Prativa Sherchan; John H Zhang
Journal:  Neurochem Int       Date:  2011-12-30       Impact factor: 3.921

4.  Tetramethylpyrazine Protects Against Oxygen-Glucose Deprivation-Induced Brain Microvascular Endothelial Cells Injury via Rho/Rho-kinase Signaling Pathway.

Authors:  Guang Yang; Chen Qian; Ning Wang; Chenyu Lin; Yan Wang; Guangyun Wang; Xinxin Piao
Journal:  Cell Mol Neurobiol       Date:  2016-07-05       Impact factor: 5.046

Review 5.  Long Non-coding RNAs (lncRNAs), A New Target in Stroke.

Authors:  Ziyu Wang; Xiang Li; Liangliang Huang; Ge Liu; Yan Chen; Binbin Li; Xueyan Zhao; Rong Xie; Yunman Li; Weirong Fang
Journal:  Cell Mol Neurobiol       Date:  2020-08-31       Impact factor: 5.046

Review 6.  Stroke, Vascular Dementia, and Alzheimer's Disease: Molecular Links.

Authors:  Murali Vijayan; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2016-09-06       Impact factor: 4.472

7.  PKC-β exacerbates in vitro brain barrier damage in hyperglycemic settings via regulation of RhoA/Rho-kinase/MLC2 pathway.

Authors:  Kirtiman Srivastava; Beili Shao; Ulvi Bayraktutan
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-21       Impact factor: 6.200

8.  The cross-talk between canonical and non-canonical Wnt-dependent pathways regulates P-glycoprotein expression in human blood-brain barrier cells.

Authors:  Martha L Pinzón-Daza; Iris C Salaroglio; Joanna Kopecka; Ruth Garzòn; Pierre-Olivier Couraud; Dario Ghigo; Chiara Riganti
Journal:  J Cereb Blood Flow Metab       Date:  2014-06-04       Impact factor: 6.200

Review 9.  Blood-brain barrier dysfunction and recovery after ischemic stroke.

Authors:  Xiaoyan Jiang; Anuska V Andjelkovic; Ling Zhu; Tuo Yang; Michael V L Bennett; Jun Chen; Richard F Keep; Yejie Shi
Journal:  Prog Neurobiol       Date:  2017-10-05       Impact factor: 11.685

Review 10.  Rapamycin in ischemic stroke: Old drug, new tricks?

Authors:  Gina Hadley; Daniel J Beard; Yvonne Couch; Ain A Neuhaus; Bryan A Adriaanse; Gabriele C DeLuca; Brad A Sutherland; Alastair M Buchan
Journal:  J Cereb Blood Flow Metab       Date:  2018-10-18       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.